FIBROBIOLOGICS ($FBLG) posted quarterly earnings results for Q2 2026 on Friday, July 31st. The company reported earnings of -$0.66 per share, beating estimates of -$0.73 by $0.07. The company also reported revenue of $0, equaling estimates of $0 by $0.
You can see Quiver Quantitative's $FBLG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
FIBROBIOLOGICS Insider Trading Activity
FIBROBIOLOGICS insiders have traded $FBLG stock on the open market 6 times in the past 6 months. Of those trades, 6 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $FBLG stock by insiders over the last 6 months:
- JASON DAVIS (Chief Financial Officer) purchased 70,000 shares for an estimated $28,973
- PETE O'HEERON (CHIEF EXECUTIVE OFFICER) has made 3 purchases buying 51,500 shares for an estimated $19,530 and 0 sales.
- RUBEN A GARCIA (General Counsel) purchased 40,000 shares for an estimated $13,056
- HAMID KHOJA (Chief Scientific Officer) purchased 30,000 shares for an estimated $11,400
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
FIBROBIOLOGICS Hedge Fund Activity
We have seen 1 institutional investors add shares of FIBROBIOLOGICS stock to their portfolio, and 40 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 457,754 shares (-94.9%) from their portfolio in Q1 2026, for an estimated $604,235
- GEODE CAPITAL MANAGEMENT, LLC removed 319,152 shares (-91.5%) from their portfolio in Q1 2026, for an estimated $421,280
- RENAISSANCE TECHNOLOGIES LLC removed 215,603 shares (-93.1%) from their portfolio in Q1 2026, for an estimated $284,595
- JANE STREET GROUP, LLC removed 149,763 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $197,687
- AMG NATIONAL TRUST BANK removed 138,960 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $183,427
- UBS GROUP AG removed 115,049 shares (-95.3%) from their portfolio in Q1 2026, for an estimated $151,864
- STATE STREET CORP removed 111,300 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $146,916
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
FIBROBIOLOGICS Price Targets
Multiple analysts have issued price targets for $FBLG recently. We have seen 2 analysts offer price targets for $FBLG in the last 6 months, with a median target of $7.5.
Here are some recent targets:
- Matthew Caufield from HC Wainwright & Co. set a target price of $8.0 on 04/16/2026
- Jason Kolbert from D. Boral Capital set a target price of $7.0 on 03/12/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
